课题基金 / 基金详情

Involvement of ubiquitin system on the hepatitis B virus X protein (HBx)-mediated transactivation activity

Involvement of ubiquitin system on the hepatitis B virus X protein (HBx)-mediated transactivation activity
泛素系统参与乙型肝炎病毒 X 蛋白 (HBx) 介导的反式激活活性
批准号:
17590274
负责人:
TOKUNAGA Fuminori
金额:
$2.18万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2005
资助国家:
日本
项目状态:
已结题
起止时间:
2005 至 2006

项目摘要

项目成果

TOKUNAGA Fuminori的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
We have identified an RING-IBR-RING (RBR) family ubiquitin ligase, HOIL-1L, as a predominant intracellular isoform of HOIL-1 (heme-oxidized IRP2 ligase-1). HOIL-1L forms a high molecular mass (〜600 kDa) complex with HOIP (HOIL-1L-interacting protein) in vivo. HOIP also belongs to RBR family, and the HOIL-1L/HOIP complex exhibits ubiquitin polymerization activity in vitro. To examine the physiological function of HOIL-1L/HOIP, we first screened the effect of HOIL-1L/HOIP on transcriptional activity, since HOIL-1 has shown to bind protein kinase C and hepatitis B virus X protein, and both of them affect transcription. Then, we found by luciferase reporter assay that combined expression of HOIL-1L and HOIP, but not by single expression of respective ligase, specifically induced NF-KB activation. Indeed, co-expression of HOIL-1L/HOIP caused intranuclear translocation of p65 and p50, and enhanced phosphorylation of IKBa. Using various domain-deleted mutants, we identified that the RING domains of HOIP played a crucial role on the NF-KB activation. Notably, a dysfunctional RING-finger mutant of HOIP inhibited TNF-a-and TAK1-mediated NF-KB activation, but had no effect on NIK-mediated NF-KB activation. These results indicate that HOIL-1L/HOIP activates canonical NF-KB pathway through the ubiquitin ligase activity of HOIP. The ligase complex may have a pivotal role on the inflammation, anti-apoptosis, and immune system through the regulation of NF-KB pathway.
期刊论文(12)
专著(0)
科研奖励(0)
会议论文
Characterization of endoplasmic reticulum-associated degradation of a protein S mutant identified in a family of quantitative protein S deficiency.
在定量蛋白 S 缺陷家族中鉴定的蛋白 S 突变体的内质网相关降解的表征。
DOI: --
发表时间: 2005
期刊: Thromb.Res. (in press)
影响因子: --
作者: [Hitomi HAYABUCHI, Manami HISANO, Yasuko MATSUNAGA, Yasumi Kimura, Ohnaka Keizo, Tsuda Hiroko]
通讯作者: Tsuda Hiroko
A ubiquitin ligase complex assembles linear polyubiquitin chain
泛素连接酶复合物组装线性多泛素链
DOI: --
发表时间: 2006
期刊: EMBO J. 25・20
影响因子: --
作者: [Kirisako, T. et al.]
通讯作者: T. et al.
実験医学増刊 細胞内タンパク質の社会学
实验医学特刊细胞内蛋白质社会学
DOI: --
发表时间: 2005
期刊:
影响因子: --
作者: [Tabayashi T, Ishimaru F, Takata M, etal., 徳永 文稔]
通讯作者: 徳永 文稔
DOI: 10.1016/j.bbrc.2006.09.163
发表时间: 2006-12-15
期刊: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
影响因子: 3.1
作者: [Nakamura, Munehiro, Tokunaga, Fuminori, Iwai, Kazuhiro]
通讯作者: Iwai, Kazuhiro
Identification of deubiquitinases, which regulate inflammatory and immune signaling pathways, and screening for their inhibitors
  • 批准号:
    16K15210
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
  • 资助金额:
    $2.33万
  • 财政年份:
    2016
  • 负责人:
    TOKUNAGA Fuminori
  • 依托单位:
Screening for interactors of linear ubiquitin chain assembly complex (LUBAC), and studies on their physiological functions
Construction and application of linear ubiquitin-specific molecular probes for anti-cancer drug screening
  • 批准号:
    25670137
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
  • 资助金额:
    $2.5万
  • 财政年份:
    2013
  • 负责人:
    TOKUNAGA Fuminori
  • 依托单位:
Construction of polyubiquitin chain specific molecular probes and their applications to histopathologic examinations.
  • 批准号:
    23657075
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
  • 资助金额:
    $2.5万
  • 财政年份:
    2011
  • 负责人:
    TOKUNAGA Fuminori
  • 依托单位:
国内基金
海外基金
酶响应的中性粒细胞外泌体载药体系在眼眶骨缺损修复中的作用及机制研究
  • 批准号:
    82371102
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    苏蕴
  • 依托单位:
PCBP1和PCBP2调控cGAS的相变和酶活的机制研究
  • 批准号:
    32370928
  • 项目类别:
    面上项目
  • 资助金额:
    50.00万元
  • 批准年份:
    2023
  • 负责人:
    孙钦秒
  • 依托单位:
蛋白精氨酸甲基化转移酶PRMT5调控PPARG促进巨噬细胞M2极化及其在肿瘤中作用的机制研究
  • 批准号:
    82371738
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    郑英霞
  • 依托单位:
木质纤维素高效水解多酶混合物(multi-enzyme cocktails)的高通量分析及其理性定制
  • 批准号:
    21176106
  • 项目类别:
    面上项目
  • 资助金额:
    60.0万元
  • 批准年份:
    2011
  • 负责人:
    孙付保
  • 依托单位: